Clinical application of mid-thigh arteriovenous graft
10.3760/cma.j.issn.1001-7097.2019.06.004
- VernacularTitle:大腿中段人工血管动静脉瘘的临床应用
- Author:
Chao DENG
1
;
Jingyi HU
;
Xuedong BAO
;
Weijing GE
;
Sijie LIU
;
Shichao WANG
;
Yaxue SHI
Author Information
1. 上海中医药大学附属龙华医院血管外科
- Keywords:
Renal replacement therapy;
Hemodiafiltration;
Arteriovenous fistula;
Arteriovenous graft;
Vascular access
- From:
Chinese Journal of Nephrology
2019;35(6):421-425
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical outcomes of hemodialysis patients after superficial femoral artery - superficial femoral vein arteriovenous graft (AVG). Methods Hemodialysis patients with mid - thigh superficial femoral artery - superficial femoral vein AVG from August 2015 to March 2018 in department of vascular surgery, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine were enrolled. Their clinical outcomes and complications after operation were analyzed retrospectively. Patency rates were measured by Kaplan - Meier survival curve. Results A total of 18 cases were enrolled. The success rate of the operation was 100％without complication. Follow - up time was (22.00 ± 11.77) months with 100％ follow - up rate. The 6 months -, 12 months -, 24 months - primary patency rates were 83.3％±8.8％, 48.5％±12.1％, 24.2％± 13.5％, respectively; secondly patency rates were 100.0％, 100.0％, 87.5％±11.7％. There were 1 case of seroma, 1 case of puncture site infection, 11 cases of stenosis and 5 cases thrombosis during follow-up, while no heart failure, ischemia or pseudoaneurysm. Conclusion Mid - thigh AVG has low infection rate and high patency rate, so it can be as the first choice for the lower extremity AVG in hemodialysis patients.
